Charbel Noujaim
Overview
Explore the profile of Charbel Noujaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bidaoui G, Feng H, Chouman N, Assaf A, Lim C, Younes H, et al.
J Interv Card Electrophysiol
. 2025 Feb;
PMID: 39899141
Background: Atrial fibrillation (AF) is associated with adverse remodeling of the left atrium (LA). The impact of the extent of atrial myopathy and post-ablation remodeling on quality-of-life (QoL) outcomes has...
2.
Mekhael M, Feng H, Akoum N, Sohns C, Sommer P, Mahnkopf C, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39814192
Background: Causal machine learning (ML) provides an efficient way of identifying heterogeneous treatment effect groups from hundreds of possible combinations, especially for randomized trial data. Objective: The aim of this...
3.
Noujaim C, Feng H, Bidaoui G, Huang C, Younes H, Assaf A, et al.
J Cardiovasc Electrophysiol
. 2024 Dec;
36(2):457-466.
PMID: 39716785
Introduction: Catheter ablation of persistent atrial fibrillation yields sub-optimal success rates partly due to the considerable heterogeneity within the patient population. Identifying distinct patient phenotypes based on post-ablation prognosis could...
4.
Zalaquett Z, Hachem M, Assi A, Mohanna R, Farhat M, Noujaim C, et al.
Future Oncol
. 2024 Oct;
20(38):3151-3167.
PMID: 39373602
Antibody-drug conjugates (ADCs) have recently emerged as a promising therapeutic option that combine the specificity of monoclonal antibodies and the cytotoxic effect of chemotherapy. With numerous ADCs approved and on...
5.
Bidaoui G, Tsakiris E, Younes H, Feng H, Assaf A, Chouman N, et al.
J Cardiovasc Electrophysiol
. 2024 Oct;
35(12):2330-2341.
PMID: 39350356
Introduction: Obesity is implicated in adverse atrial remodeling and worse outcomes in patients with atrial fibrillation. The objective of this study is to assess the effect of body mass index...
6.
Younes H, Ademi B, Tsakiris E, Feng H, Pandey A, Mekhael M, et al.
J Interv Card Electrophysiol
. 2024 Sep;
PMID: 39264394
Background: Catheter ablation has obtained class 1 indication in ablation of young, healthy patients with symptomatic paroxysmal atrial fibrillation (AF). Anti-arrhythmic drugs (AADs) remain first-line therapy before ablating persistent AF...
7.
El Hajjar A, Dagher L, Younes H, Mekhael M, Noujaim C, Chouman N, et al.
J Interv Card Electrophysiol
. 2024 Jul;
67(9):2101-2109.
PMID: 39023723
Background: There is a strong relationship between left atrial (LA) remodeling and ischemic stroke (IS) risk in atrial fibrillation (AF) patients. The Efficacy of Delayed Enhancement MRI-Guided Ablation vs. Conventional...
8.
Noujaim C, Assaf A, Lim C, Feng H, Younes H, Mekhael M, et al.
Europace
. 2024 Apr;
26(5).
PMID: 38646912
Aims: Traditional atrial fibrillation (AF) recurrence after catheter ablation is reported as a binary outcome. However, a paradigm shift towards a more granular definition, considering arrhythmic or symptomatic burden, is...
9.
Noujaim C, Shan B, Kim J, Mekhael M, Feng H, Assaf A, et al.
Circ Arrhythm Electrophysiol
. 2023 Sep;
16(10):e011975.
PMID: 37750322
No abstract available.
10.
Assaf A, Noujaim C, Mekhael M, Younes H, Chouman N, Dhore-Patil A, et al.
JACC Clin Electrophysiol
. 2023 Sep;
9(11):2253-2262.
PMID: 37737783
Background: Left atrial (LA) enlargement is prevalent among atrial fibrillation (AF) patients and constitutes an important marker of atrial myopathy. Several studies have described reduction in LA volume post-catheter ablation...